Cardiac Risk Assessment in Liver Transplant Candidates: Current Controversies and Future Directions
Pranab M. Barman, Lisa B. VanWagner – 20 November 2020 – In the changing landscape of liver transplantation (LT), we are now evaluating older and sicker patients with more cardiovascular comorbidities, and the spectrum of cardiovascular disease is uniquely physiologically impacted by end‐stage liver disease. Cardiac complications are now the leading cause of morbidity and mortality in LT recipients, and the pretransplant risk is exacerbated immediately during the transplant operation and continues long term under the umbrella of immunosuppression.